Summary of efficacy and safety of currently-available obesity pharmacotherapy Tirzepatide and Emerging Approaches Besides the approval of semaglutide 2.4mg, much of the excitement in the field of obesity management also has to do with the approval of a dual GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) receptor agonist tirzepatide, which is currently approved for the management of T2D but has also shown promising results in the treatment of obesity in patients with and without T2D [28]
Beyond injury or infection, there's the risk of the pigment causing visual obstructionremember, your pupil is an aperture that opens and closes when reacting to light or other stimuli. She also points to the possibility of an allergic reaction to the pigments
One of the most common post-surgical concerns patients face is seroma formation: a treatable condition that affects 1% to 38% patients after abdominal procedures
Why are antioxidants important
Men typically carry higher proportions of visceral fat compared to women, making interventions that specifically target this depot particularly valuable for male metabolic health
Kortsalioudaki C, Taylor RM, Cheeseman P, Bansal S, Mieli-Vergani G, Dhawan A
